Mesomelic dysplasia, Nievergelt type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2633OMIM:163400Q78.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mesomelic dysplasia, Nievergelt type (also known as Nievergelt syndrome) is an extremely rare inherited skeletal disorder characterized by severe shortening and malformation of the middle segments (mesomelic segments) of the limbs — specifically the forearms and lower legs. The condition was first described by Nievergelt in 1944. The hallmark radiographic feature is a distinctive rhomboid or triangular shape of the tibia and fibula, which is considered virtually pathognomonic for this condition. The radius and ulna in the forearms may also be shortened, fused (synostosis), or malformed. Additional skeletal abnormalities can include clubfoot (talipes equinovarus), tarsal and carpal synostosis (fusion of bones in the feet and hands), and limited joint mobility, particularly at the elbows and knees. Stature is typically short due to the disproportionate limb shortening. The condition primarily affects the skeletal system, with the lower limbs generally more severely affected than the upper limbs. Intelligence and other organ systems are typically normal. The severity of limb malformation can vary even within affected families. Diagnosis is usually made in infancy or early childhood based on clinical examination and characteristic radiographic findings. There is currently no cure for Nievergelt-type mesomelic dysplasia. Treatment is symptomatic and supportive, focusing on orthopedic management of limb deformities. Surgical interventions may be considered to correct severe angular deformities, improve limb alignment, or address joint contractures. Physical therapy may help maintain mobility and function. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

MesomeliaHP:0003027Mesomelic short statureHP:0008845Skin dimpleHP:0010781
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mesomelic dysplasia, Nievergelt type.

View clinical trials →

No actively recruiting trials found for Mesomelic dysplasia, Nievergelt type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mesomelic dysplasia, Nievergelt type community →

No specialists are currently listed for Mesomelic dysplasia, Nievergelt type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mesomelic dysplasia, Nievergelt type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mesomelic dysplasia, Nievergelt typeForum →

No community posts yet. Be the first to share your experience with Mesomelic dysplasia, Nievergelt type.

Start the conversation →

Latest news about Mesomelic dysplasia, Nievergelt type

No recent news articles for Mesomelic dysplasia, Nievergelt type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mesomelic dysplasia, Nievergelt type

What is Mesomelic dysplasia, Nievergelt type?

Mesomelic dysplasia, Nievergelt type (also known as Nievergelt syndrome) is an extremely rare inherited skeletal disorder characterized by severe shortening and malformation of the middle segments (mesomelic segments) of the limbs — specifically the forearms and lower legs. The condition was first described by Nievergelt in 1944. The hallmark radiographic feature is a distinctive rhomboid or triangular shape of the tibia and fibula, which is considered virtually pathognomonic for this condition. The radius and ulna in the forearms may also be shortened, fused (synostosis), or malformed. Additi

How is Mesomelic dysplasia, Nievergelt type inherited?

Mesomelic dysplasia, Nievergelt type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mesomelic dysplasia, Nievergelt type typically begin?

Typical onset of Mesomelic dysplasia, Nievergelt type is neonatal. Age of onset can vary across affected individuals.